Particles for inhalation having rapid release properties
Abstract
The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent of any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
30 members in 11 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 88812601 | United States of America | A | |
| 88812601 | United States of America | A | |
| 01888126 | – | – | – |
| US20010888126 | – | – | – |
Members30
| Document | Office | Kind | |
|---|---|---|---|
| CA2433335A1 | Canada | A1 | |
| WO02053190A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2002141946A1 | United States of America | A1 | |
| CA2449439A1 | Canada | A1 | |
| WO03000202A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02053190A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003118513A1 | United States of America | A1 | |
| US2003125236A1 | United States of America | A1 | |
| WO03000202A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1345629A2 | European Patent Office (EPO) | A2 | |
| MXPA03011861A | Mexico | A | |
| EP1404299A2 | European Patent Office (EPO) | A2 | |
| IL158987A0 | Israel | A0 | |
| CN1518441A | China | A | |
| JP2005500309A | Japan | A | |
| JP2005504715A | Japan | A | |
| PL367399A1This record | Poland | A1 | |
| AU2002230993B2 | Australia | B2 | |
| US7048908B2 | United States of America | B2 | |
| JP2006249099A | Japan | A | |
| AU2002350606B2 | Australia | B2 | |
| NZ530123A | New Zealand | A | |
| EP1797902A2 | European Patent Office (EPO) | A2 | |
| EP1797902A3 | European Patent Office (EPO) | A3 | |
| US2008039366A1 | United States of America | A1 | |
| JP4067047B2 | Japan | B2 | |
| US2008226730A1 | United States of America | A1 | |
| US2008227690A1 | United States of America | A1 | |
| US2010026235A1 | United States of America | A1 | |
| CA2433335C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)DISC | DISC |
Numbers
- Publication, DOCDB
- 367399
- Publication, EPODOC
- PL367399
- Application
- 2367399
- Application, DOCDB
- 36739902
- Application, EPODOC
- PL20020367399
Titles2
- English
- PARTICLES FOR INHALATION HAVING RAPID RELEASE PROPERTIES
- Polish
- Cząstki do inhalacji o właściwościach szybkiego uwalniania
Classification
- CPC, 6
- A61K9/0075
- A61K9/1617
- A61K38/28
- A61K47/544
- A61P3/10
- A61P43/00
- IPC, 19
- A61K9 00
- A61K9 12
- A61K9 127
- A61K9 14
- A61K9 16
- A61K9 72
- A61K31 137
- A61K31 195
- A61K38 28
- A61K38 30
- A61K47 02
- A61K47 12
- A61K47 16
- A61K47 18
- A61K47 24
- A61K47 48
- A61L9 04
- A61P3 10
- A61P43 00